Doxorubicin Completed Phase 2 Trials for Cancer of the Ovary / Extragonadal Germ Cell Tumor Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002489Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors
NCT03804866NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
NCT01358071Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
NCT01113957A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
NCT01696032SGI-110 in Combination With Carboplatin in Ovarian Cancer
NCT00170573Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
NCT00722592Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)
NCT00945139Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)